Immunological defect in Whipple's disease.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000917:Antibody Formation; D000921:Antibody-Producing Cells; D000937:Antigen-Antibody Reactions; D004305:Dose-Response Relationship, Drug; D006084:Graft Rejection; D006801:Humans; D007111:Immunity, Cellular; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007413:Intestinal Mucosa / Q000276:immunology; D007419:Intestinal Secretions / Q000276:immunology; D037102:Lectins; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D012882:Skin Tests; D014316:Tritium; D008061:Whipple Disease / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*
D000900:Anti-Bacterial Agents; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D037102:Lectins; D014316:Tritium